ArticleThe American journal of case reports2026
Significant Improvement in High Myopic Anisometropic Amblyopia Treated With Repeated Low-Level Red-Light (RLRL) Therapy: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND High myopic anisometropic amblyopia poses a significant therapeutic challenge, as traditional interventions (spectacles, occlusion, atropine) exhibit limited efficacy in reducing anisometropia and controlling myopia progression. This case report explores the novel application of repeated low-level red-light therapy, which has been previously validated for myopia control, in addressing both amblyopia and refractive imbalance. CASE REPORT A male child was diagnosed with anisometropic myopia at the age of 5 years. Cycloplegic retinoscopy showed a refractive error of -7.75/-1.25×155 diopters in the right eye and -1.75 diopters in the left eye, with best-corrected visual acuity of 20/67 and 20/25, respectively. The axial length was 27.79 mm in the right eye and 24.43 mm in the left eye. The patient was prescribed full correction spectacles combined with red light therapy. Over 3 years of follow-up, the refractive error of the highly myopic right eye improved to -4.75/-1.75×175 diopters, with best-corrected visual acuity recovering to 20/20 and axial length shortening to 26.78 mm. The left eye remained stable with minor refractive changes. Choroidal thickness changes or device-specific factors may have contributed to the observed reduction. CONCLUSIONS In this case of high myopic anisometropic amblyopia, repeated low-level red-light therapy simultaneously normalized visual acuity and produced an unprecedented 1.01 mm axial-length reduction. This single-case observation is hypothesis-generating and does not establish causality. Larger controlled trials are warranted to validate these findings and elucidate the mechanisms before the adoption of repeated low-level red-light therapy into routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.